期刊论文

中文

实用预防医学

1006-3110

2017

24

9

1037-1039+1047

10.3969/j.issn.1006-3110.2017.09.003

湖南省自然科学基金项目（14JJ2112）；

本校为第一机构

目的 探讨蜂胶类黄酮对肺结核合并糖尿病(PTB-DM)患者的辅助治疗作用及其免疫调节机制,为寻求安全有效的PTB-DM防治措施提供参考. 方法 以PTB-DM患者120人为对象,利用随机数字表随机分为A、B、C三组,每组40人,A、B组分别按1000、2000 mg/d剂量口服含蜂胶类黄酮的蜂胶软胶囊,C组口服不含蜂胶类黄酮的蜂胶基质软胶囊作为对照,观察6个月,比较各组疗效差异、试验前后WBC及分类、T淋巴细胞亚群CD3+、CD4+、CD8+、CD4+/CD8+比值的差异. 结果 三组有效率差异有统计学意义(P=0.005),其中B组为94.6％、A组为76.9％、C组为64.1％;细胞免疫7项指标差异有统计学意义(P=0.000),其中WBC计数、中性粒细胞百分比...

Objective To explore the auxiliary therapeutic effect and immune regulating mechanism of propolis flavonoid in patients with pulmonary tuberculosis complicated by diabetes mellitus （PTB-DM）, and to provide references for seeking safe and effective PTB-DM prevention and control measures. Methods One hundred and twenty PTB-DM patients served as the objects, and were randomly divided into group A, group B and group C （each n=40） by the random digital table. The patients in group A and group B were assigned to take 1,000 mg/d and 2,000 mg/d pro...